DESLORATADINE; PSEUDOEPHEDRINE SULFATE | ORGANON | ||
5MG;240MG | |||
Yes | No | ||
2022-Sep-28 | Expired | ||
None | None | ||
None | No | ||
CLARINEX-D® 24 HOUR Extended Release Tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in patients 12 years of age and older. CLARINEX-D® 24 HOUR Extended Release Tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired. |
1 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
5MG;240MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com